Myriad Genetics (MYGN) Tops Q4 EPS by 4c
Tweet
Share
E-mail
Get Alerts MYGN Hot Sheet
Price: $19.23 +0.73%
EPS Growth %: +116.7%
Financial Fact:
Earnings per diluted share: -0.02
Today's EPS Names:
AOUT, AKTX, CHPT, More
EPS Growth %: +116.7%
Financial Fact:
Earnings per diluted share: -0.02
Today's EPS Names:
AOUT, AKTX, CHPT, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q4 EPS of ($0.12), $0.04 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $177.8 million versus the consensus estimate of $169.47 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ulta Beauty lifts guidance after Q3 results beat estimates
- Domo, Inc. (DOMO) Tops Q3 EPS by 12c
- PagerDuty, Inc. (PD) Tops Q3 EPS by 6c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
